Stoke Therapeutics, Inc. ($STOK)
Leggett Thomas โ Chief Financial Officer
Shares
1,274
Price
$32.74
Total Value
$41,710.00
Nearby Earnings
Mar 17, 2026
EPS:-0.99 (est: -0.92)+8.1%
Revenue:$1.40M (est: $6.24M)-77.5%
Mar 24, 2026
EPS:Est: -0.93
Revenue:Est: $6.24M
Transaction Details
| Insider | Leggett Thomas |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Mar 17, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 19, 2026 |
| Shares Sold | 1,274 |
| Price per Share | $32.74 |
| Total Value | $41,710.00 |
| Shares Owned After | 13,476 |
| Derivative | No |
| Accession Number | 0001774690-26-000006 |
| Document | View SEC Filing |